Skip to main content
. Author manuscript; available in PMC: 2024 Jan 25.
Published in final edited form as: Adv Exp Med Biol. 2021;1264:131–153. doi: 10.1007/978-3-030-57369-0_9

Fig. 9.1.

Fig. 9.1

Schematic of ECS neuro-immune signaling in neuropsychiatric disorders. In our studies, we used both IBA1 and CD11b antibodies, as IBA1 is a good marker that does not cross-react with neurons and astrocytes, while CD11b is a good marker for changes in microglia morphology